Beta Blockers for Peripheral Arterial Disease

European Journal of Vascular and Endovascular Surgery

Volumn 38, Issue 1, 2009, Pages 66-70

  Paravastu, S C V ^a   Mendonca, D A ^b   da Silva, A ^c  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b Wrexham Maelor Hospital ^*  (United Kingdom)

^c WREXHAM MAELOR HOSPITAL   (United Kingdom)

Author keywords

Beta blockers; Intermittent claudication; Peripheral vascular disease

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; LABETALOL; METHYLDOPA; METOPROLOL; NIFEDIPINE; PINDOLOL; PLACEBO; PROPRANOLOL;

ABSENCE OF SIDE EFFECTS; ARTERY DISEASE; ARTICLE; BLOOD FLOW; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GASTROCNEMIUS MUSCLE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN TEMPERATURE; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR RESISTANCE; WALKING;

ADRENERGIC BETA-ANTAGONISTS; HUMANS; INTERMITTENT CLAUDICATION; PERIPHERAL VASCULAR DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 67349083325     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.02.019     Document Type: Article

References (17)

1. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. New England Journal of Medicine 344 21 (2001) 1608-1621
2. Lassila R., Lepantalo M., and Lindfors O. Peripheral arterial disease - natural outcome. Acta Medica Scandinavica 220 4 (1986) 295-301
3. Hughson W.G., Mann J.I., and Garrod A. Intermittent claudication: prevalence and risk factors. British Medical Journal 1 6124 (1978) 1379-1381
4. Kannel W.B., and McGee D.L. Update on some epidemiologic features of intermittent claudication: the Framingham study. Journal of the American Geriatrics Society 33 1 (1985) 13-18
5. Criqui M.H., Fronek A., Barrett-Connor E., Klauber M.R., Gabriel S., and Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 71 3 (1985) 510-515
6. MIAMI Trial Researchers. Metoprolol in acute myocardial infarction. Other clinical findings and tolerability. The MIAMI trial research group. American Journal of Cardiology 56 14 (1985) G39-G46
7. American College of Cardiologists/American Heart Association. Guidelines: class 1 indications of beta-blockers. www.acc.org.
8. George C.F. Beta-receptor blocking agents. Prescribers Journal 14 (1974) 93-98
9. Joint Formularly Committee. British national formulary vol. 54 (2007), British Medical Association and Royal Pharmaceutical Society of Great Britain, London
10. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary?. Controlled Clinical Trials 17 1 (1996) 1-12
11. Schulz K.F., Chalmers I., Hayes R.J., and Altman D.G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 5 (1995) 408-412
12. Clement D.L. Studies on the effect of alpha- and beta- adrenergic blocking agents on the circulation in human limbs. XLII. Verhandelingen Van De Koninklijke Academie voor Geneekunde van Belgie 42 3-4 (1980) 164-214
13. Lepantalo M. Chronic effects of metoprolol and methyldopa on calf blood flow in intermittent claudication. British Journal of Clinical Pharmacology 18 1 (1984) 90-93
14. Lepantalo M. Chronic effects of labetalol, pindolol, and propranolol on calf blood flow in intermittent claudication. Clinical Pharmacology and Therapeutics 37 1 (1985) 7-12
15. Hiatt W.R., Stoll S., and Nies A.S. Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease. Circulation 72 6 (1985) 1226-1231
16. Roberts D.H., Tsao Y., McLoughlin G.A., and Breckenridge A. Placebo controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication. Lancet ii 8560 (1987) 650-653
17. Solomon S.A., Ramsay L.E., Yeo W.W., Parnell L., and Morris-Jones W. Beta-blockade and intermittent claudication: placebo controlled trial of atenolol, nifedipine and their combination. BMJ 303 6810 (1991) 1100-1104